Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)
Clinical trial NCT05082415 · COMPLETED
Trial details
- NCT number
- NCT05082415
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-03
- Primary completion
- 2020-12-15
- Enrollment
- 9456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.